Press Release Contact

Press release:
While Cannabinoids are their specialty, CNBX Pharmaceuticals Inc.’s Value lies in Drug Discovery
December 22, 2022, 16:41 GMT

For questions about this press release, please contact the person or organization listed below.

Nathan Culotta
Landon Capital
+1 404-995-6671
Visit us on social media:
X
LinkedIn